Absence of bleeding upon dual antiplatelet therapy in a patient with a immune GPVI deficiency.

We report the case of a patient presenting an acquired GPVI deficiency different from those previously described: (i) he is male whereas all previous cases were female, (ii) he is heterozygous for a mutation in α (alpha)-actinin-1 gene and (iii) he was treated with dual antiplatelet therapy with no haemorrhagic manifestation. PMID: 32627625 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32627625?dopt=Abstract

Source: Platelets - July 8, 2020 Category: Hematology Tags: Platelets Source Type: research

More News: Bleeding | Genetics | Hematology | Thrombocytopenia | Thrombosis